Exhibition · New York
Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy
Health · Biochemistry
Key numbers
- Editions on record
- 1first in 2010
About Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy
The Ninth Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy congress will address emerging data that underlie the optimal management of early-stage and locally advanced breast cancer. The congress will include an in-depth discussion of the increasing number of breast cancer subtypes that challenge oncologists. A significant emphasis on case discussions and new data supporting adjuvant and neoadjuvant treatment options will provide a forum for discussion of the practical applicability of evolving clinical trial findings. Other topics pertaining to predictive biomarkers, staging, risk assessment, toxicity management, and survivorship will also be addressed.
The purpose of this congress is to provide an update on the latest advances in the management of early-stage and locally advanced breast cancer and to address key areas of controversy concerning treatment in those settings.
From our listing of this edition. Details may have changed since.
Editions
| Year | Dates | Where | Exhibitors | Visitors |
|---|---|---|---|---|
| 2010 | 8–10 Oct 2010 | Sheraton New York Hotel and Towers New York | — | — |
Past editions from the bvents archive (2008–2019) and organiser figures where they were published.
Questions
When is Annual Controversies in Breast Cancer: Adjuvant and Neoadjuvant Therapy?
The next dates haven't been confirmed. The last edition we have on record was 8–10 Oct 2010.
Where is it held?
The last edition we have was at Sheraton New York Hotel and Towers, New York.